Cytoflavin in the Complex Rehabilitation of Stroke Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.
Also called NCT05935787
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 240 participants
- Sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Registry
-
NCT05935787
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Russia
- Registry status
- Completed
Technical summary
Registry record NCT05935787. Randomized; triple masking; primary purpose treatment. Start 2023-06-30 (actual); primary completion 2024-06-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cytoflavin in the Complex Rehabilitation of Stroke Patients
- Condition
- Stroke
- Intervention (Drug)
- Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
- Intervention (Drug)
- Placebo
- Lead sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
Record details
- Record id
cardio:ct-nct05935787- Content hash
03d56014263942e2136d626f24572fe388914949a447fdda4d14d475ec2404eb